Anoop Karippot, MD
Sleep Medicine · San Diego, CANPI 1609979871
Payments from drug & device makers
Across 25 payments — averaging $80.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$2K
- Jazz Pharmaceuticals Inc.$159
- Neurelis, Inc.$118
- Neuronetics, Inc.$60
- Kaleo, Inc.$35
- Novartis$21
- plus $66 from 5 others
What the payments were for
- Consulting fees$1,35067%
- Food & beverage$66433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 5 | $1,555 |
| Jazz Pharmaceuticals Inc. | 9 | $159 |
| Neurelis, Inc. | 1 | $118 |
| Neuronetics, Inc. | 2 | $60 |
| Kaleo, Inc. | 2 | $35 |
| Novartis | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Phadia US Inc. | 1 | $13 |
| Philips North America LLC | 1 | $12 |
| Itamar Medical Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,014 in reported general payments places this provider in the 55th percentile of 200 sleep medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 35 | $14,627 |
| Aripiprazole | 47 | $13,212 |
| Chlorpromazine Hcl | 24 | $5,883 |
| Bupropion XlBupropion Hcl | 117 | $1,750 |
| Olanzapine | 50 | $1,514 |
| Duloxetine Hcl | 58 | $1,164 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $1,108 |
| Quetiapine Fumarate | 72 | $993 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 22 | $969 |
| Gabapentin | 106 | $948 |
| Mirtazapine | 95 | $946 |
| Temazepam | 84 | $922 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $850 |
| Azelastine Hcl | 35 | $847 |
| Oxcarbazepine | 12 | $724 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in San Diego
- Atul MalhotraSan Diego$1.4M
- Lisa ShivesSan Diego$1.4M
- Robert OwensSan Diego$43K
- Pegah MashayekhiSan Diego$25K
- Emmanuel MignotStanford$4.7M
- Daniel NormanLos Angeles$4.2M
- Haramandeep SinghSan Ramon$1.3M
- Logan SchneiderStanford$506K
- Tony MasriLos Gatos$327K
- Clete KushidaStanford$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.